Written by Rick Meyers, FNP-BC, Functional Wellness & Aesthetics
Semaglutide is a GLP-1 receptor agonist with 94% sequence homology to human GLP-1, and it lowers body weight by reducing appetite and food intake. The part that surprises our patients in Salem is where that happens. Semaglutide has no direct action on fat cells and no measurable influence on metabolic rate.
Key Highlights
- Semaglutide is a GLP-1 receptor agonist with 94% sequence homology to human GLP-1, according to the Wegovy prescribing information.
- Three FDA-approved medications contain semaglutide: Ozempic, Wegovy and Rybelsus, each cleared for different uses.
- Weight loss follows a drop in how much food people eat, which clinical trials measure as reduced energy intake.
- In the STEP 1 trial, 1,961 adults without diabetes averaged a 14.9% reduction in body weight over 68 weeks, against 2.4% on placebo.
- Semaglutide is prescription-only, is prescribed after a medical evaluation, and is not appropriate for everyone.
| What people think semaglutide does | What the research shows |
| Speeds up your metabolism | Trials measured a drop in food intake, not a rise in energy expenditure |
| Burns or melts fat directly | No direct action on fat cells. Body fat falls because calorie intake falls |
| Keeps food sitting in your stomach | Gastric emptying slows early, and a 20-week trial found no evidence of delay by the end of it |
| Is a different drug from Ozempic | Semaglutide is the active ingredient in Ozempic, Wegovy and Rybelsus |
| Replaces willpower | Activates GLP-1 receptors in brain regions that regulate appetite and caloric intake |
Is semaglutide the same thing as Ozempic and Wegovy?
Semaglutide is the active ingredient inside Ozempic, Wegovy and Rybelsus, so all three behave the same way in the body and differ mainly in what they are approved to treat.
Ozempic is a weekly injection cleared for type 2 diabetes. Rybelsus is a daily tablet, also cleared for type 2 diabetes. Wegovy is the version the FDA approved for chronic weight management in June 2021, for adults with obesity or for adults who carry extra weight along with at least one weight-related condition such as high blood pressure or high cholesterol. Wegovy later gained a second indication for reducing the risk of major cardiovascular events in adults with established heart disease.
Patients often arrive having read about one brand and been prescribed another, which is where most of the confusion starts. If you want the brand-by-brand version, we covered the difference between Wegovy and Ozempic separately.
How does semaglutide work in the body?
Semaglutide works by binding to GLP-1 receptors, the same docking points your own glucagon-like peptide-1 uses after a meal.
GLP-1 is a hormone your gut releases when food arrives. Its job is to tell the pancreas to release insulin, tell the liver to ease off on glucose production, and tell the brain that eating can stop. Natural GLP-1 breaks down within minutes. Semaglutide is built to resist that breakdown, which is why a single injection keeps signaling for days rather than moments. The Wegovy prescribing information puts its half-life at roughly one week, and we go deeper into that in our post on how long semaglutide stays in your system.
Four things happen once those receptors are activated. They are listed here in order of how much each contributes to weight loss, which is close to the reverse of how most articles present them.
Appetite signaling in the brain. The Wegovy prescribing information describes GLP-1 as a physiological regulator of appetite and caloric intake, and notes that GLP-1 receptors sit in several brain regions involved in appetite regulation. Activating them lowers hunger and raises the sense of fullness.
Hunger behaves less like a switch and more like a thermostat. A thermostat set to 74 degrees will keep pushing the room back to 74 no matter how many windows you open. Semaglutide moves the setting rather than fighting the room, which is why patients describe food noise going quiet instead of describing a struggle they finally won.
Glucose-dependent insulin release. Semaglutide prompts the pancreas to release more insulin, but only when blood sugar is already high. That conditional trigger is why the medication carries a lower risk of driving blood sugar too low than older diabetes drugs.
Glucagon suppression. Glucagon is the hormone that tells the liver to push stored glucose into the blood. Semaglutide dials that signal down, which steadies blood sugar between meals.
Slowed gastric emptying. Food leaves the stomach more slowly in the early weeks of treatment. This one gets quoted more than any of the others, and it deserves a closer look.
How long does it take for semaglutide to suppress appetite?
Appetite changes are often noticeable within the first week or two, well ahead of any meaningful movement on the scale. The appetite effect and the weight effect run on different clocks, because eating less takes time to accumulate into pounds. Our guide to how long semaglutide takes to work walks through that timeline in detail.
Does semaglutide speed up your metabolism?
No. Semaglutide changes the intake side of the equation rather than the output side. Clinical trials that measured what participants ate found large reductions in energy intake, and researchers attribute the weight loss to that reduction rather than to any rise in the rate at which the body burns energy at rest.
Does semaglutide burn fat?
No. Semaglutide has no direct action on fat cells. Body fat falls for the same reason it falls in any sustained calorie deficit: the body draws on stored energy when less arrives from food. What the medication does is make that smaller intake feel manageable instead of feeling like deprivation.
Does semaglutide really slow your stomach down?
Semaglutide does slow gastric emptying early in treatment, but that effect appears to fade, and it is not what keeps the weight coming off months later.
A randomized trial of 72 adults with obesity tested this directly. Researchers gave participants once-weekly semaglutide or placebo for 20 weeks and measured stomach emptying using paracetamol absorption. Appetite fell, control of eating improved, food cravings dropped, and body weight fell by 9.9% against 0.4% on placebo. Gastric emptying moved in the opposite direction from what the popular explanation predicts, and the trial found no evidence of delayed gastric emptying at week 20. A separate 20-week trial of oral semaglutide reached the same conclusion.
Read that carefully, because it reframes the whole mechanism. The stomach effect is real when treatment starts, which is a large part of why nausea and early fullness cluster in the first weeks. By month five the stomach effect is no longer detectable, while appetite suppression and weight loss both continue, which points to the brain signal as the durable one. Slowed emptying is also the source of most early side effects, which we cover in our piece on the first week on semaglutide.
How does semaglutide work for weight loss?
Semaglutide produces weight loss by lowering how much food people eat, and researchers have measured the size of that effect in large trials.
The best known is STEP 1, published in the New England Journal of Medicine in 2021. Investigators enrolled 1,961 adults who had obesity, or who carried extra weight along with at least one weight-related condition, and who did not have diabetes. Participants received once-weekly semaglutide injections or placebo for 68 weeks, and everyone received lifestyle counseling. Mean body weight change was 14.9% with semaglutide against 2.4% with placebo. Novo Nordisk, which makes semaglutide, designed and funded the trial.
Those figures describe what a specific group of participants averaged under trial conditions across more than a year. They are not a forecast for any individual, and a mean hides a wide spread of results in both directions. Anyone quoting a number as what you personally will lose is quoting something the research does not support. Our semaglutide weight management program starts from your health history rather than from an average.
Whether semaglutide belongs in your plan depends on your health history, not on how the medication works.
Ask Rick whether semaglutide fits your history
Consultations at our Salem office are free and start with a full health review.
Why does semaglutide seem to stop working?
Semaglutide rarely stops working in a pharmacological sense. What changes is the balance between the appetite signal the medication provides and the body’s own defense of the weight it used to carry.
Two things shift over a long course of treatment. Appetite regulation adapts, so the hunger that went quiet early on becomes more noticeable later. At the same time, a smaller body needs less energy to run, so the same eating pattern that once produced steady loss eventually matches what the body spends. The plateau that follows is a predictable feature of weight loss rather than a sign the medication failed.
Providers respond to a stall by looking at adherence, sleep, alcohol, muscle mass, other medications and thyroid function. Our post on why weight loss stalls on semaglutide covers what we check first.
Is semaglutide safe, and who should not take it?
Semaglutide is prescription-only, is prescribed after a medical evaluation, and is not appropriate for everyone.
The prescribing information carries a boxed warning. In rodents, semaglutide caused thyroid C-cell tumors at clinically relevant exposures. Whether the same risk applies to humans has not been determined. Because of that finding, semaglutide is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma, and for anyone with multiple endocrine neoplasia syndrome type 2.
The label also carries warnings for pancreatitis, gallbladder disease including gallstones, low blood sugar, acute kidney injury, worsening diabetic retinopathy, increased heart rate, and suicidal behavior or ideation. The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, abdominal pain and constipation. In STEP 1, nausea and diarrhea were the most frequently reported adverse events, and more participants on semaglutide than on placebo stopped treatment because of gastrointestinal effects.
Red flags that mean you call your provider rather than wait:
- Severe or persistent abdominal pain, particularly pain that radiates to the back
- Vomiting that stops you keeping fluids down
- A lump or swelling in the neck, difficulty swallowing, or persistent hoarseness
- Changes in vision
- Any new thoughts of self-harm
Our guide to common Ozempic side effects covers which reactions usually settle and which ones do not.
Does compounded semaglutide work the same way?
Compounded semaglutide is not an FDA-approved product, and the rules governing it changed in 2025.
Compounding pharmacies were permitted to make copies of semaglutide while the FDA listed it as being in shortage. In February 2025 the agency declared that shortage resolved. A period of enforcement discretion followed, and the FDA’s policy update for compounders records that the window for state-licensed pharmacies operating under section 503A ended in April 2025, after a district court declined to block the decision.
The practical point for patients is about oversight. Compounded preparations do not go through FDA review for safety, effectiveness or quality, so purity, potency and sterility rest on the compounder rather than on a federal review process. Ask any provider which specific product they dispense and whether it is FDA-approved, and expect a direct answer. Pricing between the two paths differs, and we broke that down in our look at compounded versus FDA-approved pricing.
TL;DR
- Semaglutide is a GLP-1 receptor agonist with 94% sequence homology to human GLP-1, and it is the active ingredient in Ozempic, Wegovy and Rybelsus.
- The main mechanism is appetite regulation in the brain, which lowers food intake, rather than any change to metabolic rate or fat cells.
- Slowed gastric emptying is an early effect that fades. A 20-week trial found no evidence of delay by its end, while appetite suppression and weight loss continued.
- In STEP 1, participants averaged 14.9% body weight reduction over 68 weeks against 2.4% on placebo, in a Novo Nordisk-funded trial of 1,961 adults without diabetes.
- Semaglutide is prescription-only, carries a boxed warning for thyroid C-cell tumors seen in rodents, and is not suitable for everyone.
The mechanism is the same for every person who takes semaglutide. Whether it belongs in your plan is a separate question, and it needs your history to answer.
Book a free consultation in Salem
Provider-led care from Rick Meyers, FNP-BC, at Functional Wellness & Aesthetics.
Frequently Asked Questions
What does semaglutide do to your body?
Semaglutide activates GLP-1 receptors in the brain and pancreas. That lowers appetite and food intake, prompts insulin release when blood sugar is high, reduces glucagon output from the liver, and slows stomach emptying in the early weeks. The combined result is lower blood sugar and reduced body weight.
Does semaglutide suppress appetite immediately?
Appetite changes often begin within the first week or two of treatment, though the degree varies between people and builds as a provider adjusts the plan. Weight change lags behind the appetite change, because reduced eating needs time to accumulate. A provider tracks both separately.
How long does semaglutide stay in your system?
The Wegovy prescribing information puts the half-life at roughly one week, which is why the injectable form is given weekly. Full clearance after stopping takes several weeks. Appetite generally returns during that period, which is one reason providers plan any stop rather than letting it happen abruptly.
Does oral semaglutide work as well as injectable?
Both forms activate the same GLP-1 receptors through the same mechanism, and a 20-week trial of oral semaglutide found reductions in energy intake, appetite and body weight comparable in character to the injectable results. Approved uses differ by product, so which form suits you is a clinical decision.
Do you need a prescription for semaglutide?
Yes. Every FDA-approved semaglutide product is prescription-only, and a prescription follows a medical evaluation that reviews your health history, current medications and contraindications. Products sold without that evaluation sit outside the approved supply chain, and their contents carry no guarantee of purity or potency.
About the Author
Rick Meyers, FNP-BC, is the founder of Functional Wellness & Aesthetics in Salem, Oregon. He brings nearly 30 years of medical experience to the practice he opened in 2020, with training spanning medically supervised weight management, GLP-1 therapy, laser treatments, dermal fillers, skin rejuvenation, pain management and addiction treatment. Rick personally oversees the semaglutide program described in this guide. Patients can reach the clinic at 503-991-8549 or book a free consultation at the Salem office on Ramsgate Square SE.
